Serge Belanger
Stock Analyst at Needham
(3.99)
# 520
Out of 4,868 analysts
358
Total ratings
49.1%
Success rate
10.64%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Serge Belanger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NAMS NewAmsterdam Pharma Company | Reiterates: Buy | $40 | $18.20 | +119.78% | 9 | Jun 12, 2025 | |
| LQDA Liquidia | Maintains: Buy | $25 → $32 | $13.64 | +134.60% | 32 | Jun 2, 2025 | |
| ARQT Arcutis Biotherapeutics | Reiterates: Buy | $20 | $13.67 | +46.36% | 21 | May 23, 2025 | |
| VRDN Viridian Therapeutics | Reiterates: Buy | $36 | $15.00 | +140.08% | 17 | May 20, 2025 | |
| TRVI Trevi Therapeutics | Reiterates: Buy | $24 | $6.07 | +295.39% | 21 | May 20, 2025 | |
| OMER Omeros | Reiterates: Hold | n/a | $3.22 | - | 7 | May 16, 2025 | |
| CLSD Clearside Biomedical | Maintains: Buy | $4 → $3 | $0.79 | +279.75% | 15 | May 15, 2025 | |
| VRCA Verrica Pharmaceuticals | Reiterates: Hold | n/a | $0.58 | - | 19 | May 14, 2025 | |
| CYTK Cytokinetics | Reiterates: Buy | $72 | $32.73 | +120.02% | 23 | May 14, 2025 | |
| MLTX MoonLake Immunotherapeutics | Reiterates: Buy | $66 | $43.50 | +51.72% | 13 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $55 | $31.90 | +72.41% | 12 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $30 | $24.34 | +23.25% | 28 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $9.30 | +136.69% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $15 | $13.58 | +10.46% | 17 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.10 | +263.64% | 20 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $14 | $8.32 | +68.27% | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $17 | $9.97 | +70.51% | 13 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $2.00 | +100.00% | 22 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $25.34 | - | 5 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $46 | $29.60 | +55.41% | 25 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $28 | $12.32 | +127.27% | 20 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.56 | - | 1 | Mar 31, 2022 |
NewAmsterdam Pharma Company
Jun 12, 2025
Reiterates: Buy
Price Target: $40
Current: $18.20
Upside: +119.78%
Liquidia
Jun 2, 2025
Maintains: Buy
Price Target: $25 → $32
Current: $13.64
Upside: +134.60%
Arcutis Biotherapeutics
May 23, 2025
Reiterates: Buy
Price Target: $20
Current: $13.67
Upside: +46.36%
Viridian Therapeutics
May 20, 2025
Reiterates: Buy
Price Target: $36
Current: $15.00
Upside: +140.08%
Trevi Therapeutics
May 20, 2025
Reiterates: Buy
Price Target: $24
Current: $6.07
Upside: +295.39%
Omeros
May 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $3.22
Upside: -
Clearside Biomedical
May 15, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $0.79
Upside: +279.75%
Verrica Pharmaceuticals
May 14, 2025
Reiterates: Hold
Price Target: n/a
Current: $0.58
Upside: -
Cytokinetics
May 14, 2025
Reiterates: Buy
Price Target: $72
Current: $32.73
Upside: +120.02%
MoonLake Immunotherapeutics
May 13, 2025
Reiterates: Buy
Price Target: $66
Current: $43.50
Upside: +51.72%
May 13, 2025
Maintains: Buy
Price Target: $60 → $55
Current: $31.90
Upside: +72.41%
May 9, 2025
Maintains: Buy
Price Target: $32 → $30
Current: $24.34
Upside: +23.25%
May 8, 2025
Reiterates: Buy
Price Target: $22
Current: $9.30
Upside: +136.69%
May 7, 2025
Maintains: Buy
Price Target: $12 → $15
Current: $13.58
Upside: +10.46%
May 7, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $1.10
Upside: +263.64%
May 6, 2025
Maintains: Buy
Price Target: $15 → $14
Current: $8.32
Upside: +68.27%
May 6, 2025
Maintains: Buy
Price Target: $15 → $17
Current: $9.97
Upside: +70.51%
Apr 11, 2025
Reiterates: Buy
Price Target: $4
Current: $2.00
Upside: +100.00%
Apr 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $25.34
Upside: -
Apr 9, 2025
Reiterates: Buy
Price Target: $46
Current: $29.60
Upside: +55.41%
Apr 8, 2025
Reiterates: Buy
Price Target: $28
Current: $12.32
Upside: +127.27%
Mar 31, 2022
Downgrades: Hold
Price Target: n/a
Current: $3.56
Upside: -